CYCU:NASDAQCycurion, Inc. Analysis
Data as of 2026-06-14 - not real-time
$0.64
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Cycurion’s stock trades at $0.637, well below its 20‑day (≈$0.855) and 50‑day (≈$0.969) simple moving averages, confirming a bearish technical backdrop. The 14‑day RSI sits at 30.8, edging into oversold territory, while the MACD line remains negative and the histogram is contracting, suggesting limited upward momentum in the near term. Volume has been trending down and 30‑day volatility is extreme at roughly 96 %, compounded by a beta of 1.8, which makes the share highly sensitive to market swings. Fundamentally, the company reports a PE of 0.38 versus an industry average of 36.8 and a price‑to‑book of 0.20, yet earnings are deeply negative (operating margin –72 %) and debt exceeds cash by $6 M, flagging substantial financial strain. Despite these challenges, the latest press releases highlight a 900‑bp gross‑margin expansion, a 51 % reduction in net loss, and new revenue visibility of $21‑$22 M, alongside strategic acquisitions of Secuvant and Halo Privacy that could broaden its AI‑driven cybersecurity platform. The discounted cash‑flow model assigns a fair value of $3.95, implying an implied upside of nearly 900 % if the turnaround materializes.
Given the extreme volatility, high beta, thin market cap (~$5.5 M) and decreasing liquidity, the stock carries a high overall risk rating. The upside potential is attractive but contingent on the company’s ability to convert the announced margin improvements and acquisitions into sustainable cash flow and to deleverage its balance sheet. Analysts coverage is minimal (one analyst, no consensus rating), reinforcing the uncertainty around price targets. In the short run the technical signals remain bearish, suggesting a cautious hold, while the medium‑ to long‑term narrative leans toward a speculative buy for investors comfortable with a high‑risk, high‑reward play.
Given the extreme volatility, high beta, thin market cap (~$5.5 M) and decreasing liquidity, the stock carries a high overall risk rating. The upside potential is attractive but contingent on the company’s ability to convert the announced margin improvements and acquisitions into sustainable cash flow and to deleverage its balance sheet. Analysts coverage is minimal (one analyst, no consensus rating), reinforcing the uncertainty around price targets. In the short run the technical signals remain bearish, suggesting a cautious hold, while the medium‑ to long‑term narrative leans toward a speculative buy for investors comfortable with a high‑risk, high‑reward play.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price below moving averages
- negative MACD
- decreasing volume
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- gross margin expansion
- revenue visibility increase
- strategic acquisitions
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- DCF implied upside
- potential deleveraging
- AI-driven cybersecurity market growth
Key Metrics & Analysis
Financial Health
Revenue Growth-15.50%
Profit Margin-106.97%
P/E Ratio0.4
ROE-141.86%
ROA-28.30%
Debt/Equity59.05
P/B Ratio0.2
Op. Cash Flow$-12231082
Free Cash Flow$3.0M
Industry P/E36.8
Technical Analysis
TrendBearish
RSI30.8
Support$0.58
Resistance$1.02
MA 20$0.85
MA 50$0.97
MA 200$3.23
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$3.95
Target Price$7.00
Upside/Downside998.90%
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.82
Volatility96.35%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.